Jasper Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Jasper Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire November 10, 2025 REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such […]